MedTrace Logo

Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

NCT03272971 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2019-11-01

No results posted yet for this study

Summary

The feasibility of a RF ablation catheter to bronchoscopically ablate lung tumors, will be evaluated in patients already scheduled for surgical resection.

Conditions

  • Lung Cancer
  • Lung Cancer Metastatic
  • Lung Cancer, Non-small Cell

Interventions

DEVICE

Radio-frequency Ablation

The intervention consists of a bronchoscopic approach to ablate lung tumors with radiofrequency.

Sponsors & Collaborators

  • Uptake Medical Technology, Inc.

    collaborator INDUSTRY

  • Broncus Medical Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-05
Primary Completion
2019-01-30
Completion
2019-01-30
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03272971 on ClinicalTrials.gov